San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Scripps Health Says It Will Lay Off 69 Marketing/HR Employees

San Diego-based Scripps Health will lay off 69 employees from its human resources and marketing departments this summer, according to the hospital’s president and CEO Chris Van Gorder.

Cidara Therapeutics Announces Q4, Yearly Results

Cidara Therapeutics, a clinical-stage biotech working on potential anti-fungal medications, announced financial results Friday for the fourth quarter and full 2015 year.

Tease photo

Tri-City Medical Center Replaces CEO

Tri-City Medical Center has appointed a new permanent CEO, without addressing what will happen to the old one.

Tease photo

Geneticist J. Craig Venter to Receive George Washington Carver Award

Washington D.C.-based Biotechnology Innovation Organization (BIO), the largest biotech trade group in the world, has named La Jolla geneticist J. Craig Venter as the recipient of its 2016 George Washington Carver Award for innovation in industrial biotechnology.

New Pharmacy, Lab Part of Sharp Grossmont’s Modernization

Sharp Grossmont Hospital opened a new laboratory and pharmacy this month, the first phase of a $60 million renovation project at the La Mesa hospital.

Hong Ma Named Chief Scientific Officer at Therapeutics Solutions

Therapeutics Solutions International Inc., an Oceanside-based company developing treatments for cancer and other diseases, announced Wednesday that Dr. Hong Ma has been appointed as chief scientific officer.

Ligand Pharmaceuticals Receives $6 Million Milestone Payment

La Jolla drugmaker Ligand Pharmaceuticals has earned a $6 million milestone payment from Irvine-based partner company Spectrum Pharmaceuticals.

Orexigen to Pay $60 Million for U.S. Rights to Obesity Drug

San Diego drugmaker Orexigen Therapeutics Inc. bought the U.S. rights to its flagship obesity drug from co-developer Takeda Pharmaceuticals and said it would enlist Valeant Pharmaceuticals International to sell the pill in Europe.

Tease photo

Tri-City Medical Center Board May Dismiss CEO Tim Moran

Oceanside’s Tri-City Medical Center may soon part ways with CEO Tim Moran less than two years after hiring him.

2015 Earnings Reported by Three Life Science Companies

Three San Diego life science firms reported earnings for the fourth quarter and the full year of 2015: Mast Therapeutics Inc., Biocept Inc. and Mirati Therapeutics Inc.

Japanese Billionaire Invests $40 Million in Aspyrian Therapeutics

San Diego biotech Aspyrian Therapeutics has raised $40 million to pursue a new way to fight cancer.

Tease photo

Vertex Enters Long-term Lease, Will More Than Double Local Footprint

Boston-based Vertex Pharmaceuticals is expanding its presence in San Diego.

Joe Smith Named Permanent CEO of Reflexion Health

Local health tech guru Dr. Joe Smith has been appointed the permanent CEO of Reflexion Health, a digital health company in downtown San Diego.

Tease photo

Co. Deftly Avoids Prescribed Path to Market

PHARMA: Otonomy Cuts Usual Costs, Time With Middle Ear Drug

Local drugmaker Otonomy Inc. launched its lead drug Otiprio this month, bringing the asset from the lab to market in less than eight years and without the help of Big Pharma.

Tease photo

Flatley Took Illumina From Startup to Star

TECH: CEO Steps Down; Co. in Sequencing Top Spot

Following a string of big news since the first of the year, San Diego’s Illumina Inc. announced a shakeup at headquarters — CEO Jay Flatley is stepping down.